Yonhap Infomax NewsMay 19, 2025
ImmuneOncia, Yuhan Corporation's immune-oncology subsidiary, lists on KOSDAQ, aiming for growth through technology transfers and clinical advancements in cancer treatments.
#YonhapInfomax #ImmuneOncia #YuhanCorporation #KOSDAQListing #ImmuneCancerDrugs #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63799
Yuhan Corporation's Subsidiary ImmuneOncia Lists on KOSDAQ - 'Growth Through Technology Transfer'

ImmuneOncia, Yuhan Corporation's immune-oncology subsidiary, lists on KOSDAQ, aiming for growth through technology transfers and clinical advancements in cancer treatments.

Yonhap Infomax
Yonhap Infomax NewsMay 18, 2025
Four companies set to debut on Korean stock markets this week, including Dalba Global and ImmuneOncia, with Keystron opening IPO subscription amid active listing activities.
#YonhapInfomax #IPOMarket #DalbaGlobal #ImmuneOncia #KOSDAQListing #KeystronSubscription #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63709
Four Companies to List This Week Including Dalba Global and ImmuneOncia - Keystron IPO Subscription

Four companies set to debut on Korean stock markets this week, including Dalba Global and ImmuneOncia, with Keystron opening IPO subscription amid active listing activities.

Yonhap Infomax